Exhibit 10.24
AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
This Amendment (the "Amendment") dated as of May 31, 1996 is entered into
by and among Metasyn, Inc., a Delaware corporation (the "Company"), the holders
of shares of the Company's Series A Convertible Preferred Stock, $.01 par value
per share (the "Series A Preferred"), and warrants convertible into Series A
Preferred, the holders of the Company's Series B Convertible Preferred Stock,
$.01 par value per share (the "Series B Preferred"), and warrants convertible
into Series B Preferred, the holders of Convertible Promissory Notes issued by
the Company and convertible into shares of the Company's Series C Convertible
Preferred Stock, $.01 par value per share (the "Series C Preferred"), and
warrants convertible into Series C Preferred, the purchasers of the Company's
Series D Convertible Preferred Stock, $.01 par value per share (the "Series D
Preferred"), and warrants convertible into Series D Preferred, and the purchaser
of the Company's Series E Convertible Preferred Stock, $.01 par value per share
("Series E Preferred") listed on Schedule A hereto. All capitalized words and
terms used in this Amendment and not defined herein shall have the respective
meanings ascribed to them in the Rights Agreement.
WITNESSETH:
WHEREAS, the Company, the purchasers of the Company's Series A Preferred,
the purchasers of the Company's Series B Preferred, Dominion Ventures, Inc., a
California corporation, and Dominion Fund II, a California limited partnership,
the purchasers of promissory notes dated May 26, 1995 and January 19, 1996
issued by the Company and convertible into shares of the Series C Preferred
having an aggregate original principal amount of $3,015,862.02 and the
purchasers of the Company's Series D Preferred are parties to a certain Third
Amended and Restated Stockholders' Rights Agreement dated as of May 29, 1996
(the "Rights Agreement") pursuant to which the Series A Purchasers, Series B
Purchasers, Series D Purchasers, Dominion and the Note Purchasers were granted
registration rights, rights of first refusal with respect to new equity
offerings by the Company, and certain other rights; and
WHEREAS, this Amendment is entered into as a condition to the purchase by
Daiichi Radioisotope Laboratories, Inc. ("DRL") of the Company's Series E
Preferred pursuant to a Series E Convertible Preferred Stock Purchase Agreement
dated of even date herewith by and among the Company and DRL (the "Series E
Purchase Agreement"); and
NOW THEREFORE, in consideration of the mutual promises, covenants and
conditions hereinafter set forth and other good and valuable consideration, the
parties hereto agree as follows:
1. Amendments to Rights Agreement. The Rights Agreement are hereby amended
as follows:
- 1 -
Section 1. Certain Definitions. The definitions of "Preferred Stock", "Purchase
Agreements" and "Purchasers" set forth in Section 1 are hereby deleted in their
entirety and replaced with the following:
"Preferred Stock" means collectively, the Series A Preferred, the
Series B Preferred, the Series C Preferred, the Series D Preferred and the
Series E Preferred.
"Purchase Agreements" means collectively the Series A Convertible
Preferred Stock Purchase Agreement dated as of March 25, 1992, as amended,
by and among the Company and the Series A Purchasers, the Series B
Convertible Preferred Stock Purchase Agreement dated as of March 4, 1994,
as amended, by and among the Company and the Series B Purchasers, the
Convertible Promissory Note Purchase Agreement dated as of May 26, 1995, as
amended by Amendment No. 1 to the Convertible Promissory Note Purchase
Agreement dated as of January 19, 1996, the Series D Convertible Preferred
Stock Purchase Agreement dated as of May 29, 1996 by and among the Company
and the Series D Purchasers, and the Series E Purchase Agreement.
"Purchasers" means collectively the Series A Purchasers, the Series B
Purchasers, the Note Purchasers, the Series D Purchasers and the Series E
Purchasers.
Section 4.1. Series B, C, D and E Preferred Stock. Section 4.1 of the Rights
Agreement is hereby deleted in its entirety and replaced with the following:
4.1. Series B, C, D and E Preferred Stock. (a) Except for transfers
permitted pursuant to Section 4.1(b) hereof, each of the Purchasers of the
Company's Series B Preferred Stock, Series D Preferred Stock, Series E
Preferred Stock and Notes agrees that it will not transfer any Shares,
whether now owned or hereafter acquired by such Purchaser, in any one or
more transactions, until such Purchaser (the "Selling Purchaser") notifies
the Purchasers of the Company's Series B Preferred Stock, Series D
Preferred Stock, Series E Preferred Stock and Notes (together, the
"Offerees") of the proposed transaction and gives the Offerees the
opportunity to include in the sale to the proposed transferee, upon the
same terms and conditions offered to the Selling Purchaser by such
transferee, its Shares. The number of Shares that the Selling Purchaser and
the Offerees, respectively, shall be entitled to have included in such sale
will be a number determined by multiplying the number of Shares proposed to
be sold by the Selling Purchaser multiplied by a fraction, the numerator of
which is the total number of Shares owned by the Selling Purchaser or
Shares owned by the Offerees, as the case may be, and the denominator of
which is the sum of the aggregate number of Shares then
- 2 -
owned by the Selling Purchasers and the number of Shares owned by the
Offerees. For purposes of the foregoing formula, all options, warrants and
convertible securities shall be deemed to have been exercised and/or
converted into Common Stock at the applicable exercise price or conversion
price. Each of the Offerees shall have a period of 15 days (the "Offer
Period") from the date notice of such opportunity is received to give the
Selling Purchaser written notice of its desire to participate in such sale,
stating in such notice the number of Shares desired to be sold; and if no
such notice is given within the Offer Period, such Offeree shall be deemed
to have chosen not to participate. If one or more Offerees choose (or are
deemed to have chosen) not to participate in such a sale, in whole or in
part, the Selling Purchaser shall promptly notify all other participating
Offerees, and such Offerees shall have the right, for a 5-day period
beginning on the date of such notice, to increase the number of Shares they
may sell pursuant to this Section 4.1, pro rata on the basis of the number
of Shares held by all Offerees participating in such sale, in an aggregate
amount equal to the number of Shares that such non-participating Offerees
would have been entitled to sell had they participated.
Schedule A. Schedule A to the Rights Agreement is hereby deleted in its
entirety and replaced with Schedule A hereto.
2. No Other Amendments. There have been no other changes, modifications or
alterations to the Rights Agreement except as amended hereby.
3. Entire Agreement. The Rights Agreement, as amended hereby, embodies the
entire agreement and understanding between the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements and understandings
relating to such subject matter.
4. Counterparts. This Amendment may be executed in several counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
5. Headings. The headings of the sections, subsections, and paragraphs of
this Amendment have been added for convenience only and shall not be deemed to
be a part of this Amendment.
- 3 -
IN WITNESS WHEREOF, the undersigned have hereunto set their hands as of the
day and year first above written.
METASYN, INC.
/s/ Xxxxxxx X. Xxxx
--------------------------
Xxxxxxx X. Xxxx
President
/s/ Xxxxxxx X. Xxxxxxx
--------------------------
Xxxxxxx X. Xxxxxxx
- 4 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
SUMMIT PHARMACEUTICALS
INTERNATIONAL CORPORATION
By: /s/ X. Xxxxx
--------------------------
Name: X. Xxxxx
Title: President and CEO
NIPPON SHOJI KAISHA, LTD.
By: /s/ X. Xxxxxxx
--------------------------
Name: Xxxxxxxx Xxxxxxx
Title: Managing Director
- 5 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
ACCEL IV L.P.
By: Accel IV Associates L.P.,
its General Partner
By: /s/ Xxxx Xxxxx
--------------------------
Name:
Title: General Partner
ACCEL INVESTORS '93 L.P.
By: /s/ X. Xxxxxx Sednaoui
--------------------------
Name:
Title: General Partner
ACCEL KEIRETSU L.P.
By: Accel Partners & Co., Inc.,
its General Partner
By: /s/X. Xxxxxx Sednaoui
--------------------------
Name:
Title: General Partner
XXXXXXX X. XXXXXXXXX PARTNERS
By:/s/ Xxxxxx X. Xxxxxxxxx
--------------------------
Name:
Title: General Partner
PROSPER PARTNERS
By: /s/X. Xxxxxx Sednaoui
--------------------------
Name:
Title: Attorney-in-Fact
- 6 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
BESSEMER VENTURE PARTNERS III L.P.
By: Deer III & Co.,
General Partner
By: /s/ Xxxxxx X. Xxxxxxxx
--------------------------
Name: Xxxxxx X. Xxxxxxxx
Title: General Partner
*
--------------------------
Neill X. Xxxxxxxxxx
*
--------------------------
G. Xxxxx Xxxxxxxx
*
--------------------------
Xxxxxxxxxxx Xxxxxxxx
*
--------------------------
Gabrieli Family Foundation
*
--------------------------
Xxxxx X. Xxxxx
*
--------------------------
C. Xxxxxxxx Xxxx
*
--------------------------
Xxxxxx X. Xxxxxxxx
*
--------------------------
Xxxxxx X. Xxxxxxx
- 7 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
*
--------------------------
Xxxx X. Xxxxxxx
*
--------------------------
Xxxxxx X. Xxxxx
*
--------------------------
Xxxxxxx X. Xxxxx
*
--------------------------
Xxxx X. Xxxxxxx
*
--------------------------
Xxxxxxx X. Xxxxxxx
*
--------------------------
Belisarius Corporation
*
--------------------------
Xxxxxxx Corporation
*
--------------------------
Xxxxx X. XxXxxxxxx
*
--------------------------
Xxxx X. Xxxx
*
--------------------------
Xxxxxx X. X. Xxxxxxxx
*
--------------------------
Xxxxxxx X. Xxxxxxxxxx
- 8 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
/s/ Xxxxxx X. Xxxxxxxx
--------------------------
Xxxxxx X. Xxxxxxxx
* By: /s/ Xxxxxx X. Xxxxxxxx
--------------------------
Name: Xxxxxx X. Xxxxxxxx
Title: Attorney-in-Fact
BVP III SPECIAL SITUATIONS L.P.
By: Deer III & Co.,
General Partner
By: /s/ Xxxxxx X. Xxxxxxxx
--------------------------
Name: Xxxxxx X. Xxxxxxxx
Title: General Partner
- 9 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
DOMINION VENTURES, INC.
By: /s/ Xxxxxxxx X. Xxxxxx
--------------------------
Name:
Title:
DOMINION FUND II
By: /s/ Xxxxxxxx X. Xxxxxx
--------------------------
Name:
Title:
- 10 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
ROVENT II LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ Xxxx Xxxxxxx
--------------------------
Name: Xxxx Xxxxxxx
Title: Investment Manager
ADVENT PERFORMANCE MATERIALS
LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ Xxxx Xxxxxxx
--------------------------
Name: Xxxx Xxxxxxx
Title: Investment Manager
ADWEST LIMITED PARTNERSHIP
By: Advent International Limited Partnership,
General Partner
By: Advent International Corporation, General
Partner
By: /s/ Xxxx Xxxxxxx
--------------------------
Name: Xxxx Xxxxxxx
Title: Investment Manager
- 11 -
SIGNATURE PAGE TO AMENDMENT NO. 1 TO
THIRD AMENDED AND RESTATED STOCKHOLDERS' RIGHTS AGREEMENT
ADVENT PARTNERS LIMITED
PARTNERSHIP
By: Advent International Corporation, General
Partner
By: /s/ Xxxx Xxxxxxx
--------------------------
Name: Xxxx Xxxxxxx
Title: Investment Manager
FIDELITY VENTURES, LTD.
By: /s/ Xxxx Xxxxxxxx
--------------------------
Name: Xxxx Xxxxxxxx
Title: Vice President
DAICHII RADIOISOTOPE LABORATORIES, LTD.
By: /s/ Xxxxx Xxxxx
--------------------------
Name: Xxxxx Xxxxx, M.D.
Title: President and Chief Executive Officer
- 12 -
Schedule A
Name and Address of Purchasers
Series A Purchasers
Summit Pharmaceuticals International
Corporation
Hirose 2nd Xxxx.
0-00 Xxxxxxxxxxxxxxx, Xxxxxxx-xx
Xxxxx 000 Xxxxx
Attn: X. Xxxxx
President and CEO
Nippon Shoji Kaisha, Ltd.
0-0, Xxxxxxxxx, 0-xxxxx
Xxxx-xx, Xxxxx, Xxxxx
Attn: Xxxxxxxx Xxxxxxx
Managing Director
Series B Purchasers
Accel IV L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Accel Investors '93 L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Accel Keiretsu L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxxxx Partners
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Series B Purchasers (cont.)
Prosper Partners
c/o Accel Partners
Xxx Xxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Bessemer Venture Partners III, L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
BVP III Special Situations L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Neill X. Xxxxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxxx
x/x Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
G. Xxxxx Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxxxxxx Xxxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Gabrieli Family Foundation
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
- 13 -
Series B Purchasers (cont.)
Xxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
C. Xxxxxxxx Xxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Roadakis
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Xxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Belisarius Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Dominion
Dominion Ventures, Inc.
00 Xxxxx Xxxxxx
Xxxxxx, XX 00000
Dominion Fund II
00 Xxxxx Xxxxxx
Xxxxxx, XX 00000
- 14 -
Note Purchasers
Accel IV L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Accel Investors '93 L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Accel Keiretsu L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxxxx Partners
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Prosper Partners
c/o Accel Partners
Xxx Xxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Bessemer Venture Partners III L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
BVP III Special Situations L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxxx
x/x Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
C. Xxxxxxxx Xxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Xxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Belisarius Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
- 15 -
Note Purchasers (cont.)
G. Xxxxx Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxxxxxx Xxxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Gabrieli Family Foundation
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxx X. XxXxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Xxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. X. Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Series D Purchasers
Rovent II Limited Partnership
c/o Advent International
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
Advent Performance Materials Limited
Partnership
c/o Advent International
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
Adwest Limited Partnership
c/o Advent International
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
Advent Partners Limited Partners
c/o Advent International
000 Xxxxxxx Xxxxxx
Xxxxxx, XX 00000
Fidelity Ventures Ltd.
c/o Fidelity CAPITAL
00 Xxxxxxxxxx Xxxxxx, X00X
Xxxxxx, XX 00000
Accel IV L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Accel Investors '93 L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
- 16 -
Series D Purchasers (cont.)
Accel Keiretsu L.P.
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxxxx Partners
c/o Accel Partners
Xxx Xxxxxxxxxxx Xxxxxx
Xxxxx 0000
Xxx Xxxxxxxxx, XX 00000
Prosper Partners
c/o Accel Partners
Xxx Xxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Bessemer Venture Partners III L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
BVP III Special Situations L.P.
c/o Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxxxxx
x/x Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Xxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Belisarius Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx Corporation
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
G. Xxxxx Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxxxxxx Xxxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Gabrieli Family Foundation
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxx X. XxXxxxxxx
x/x Xxxxxx X. Xxxxxxxx
Xxxxxxxx Xxxxxxx Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
- 17 -
Series D Purchasers (cont.)
Xxxxxx X. Xxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx X. Xxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxx X. X. Xxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Brimstone Island Co. L.P.
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx Xxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxx Xxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Neill X. Xxxxxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Xxxxxxx X. Xxxxxxx
c/o Xxxxxx X. Xxxxxxxx
Bessemer Venture Partners
0000 Xxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
Series E Purchaser
Daiichi Radioisotope Laboratories, Ltd.
00-00, Xxxxxxxx 0-xxxxx Xxxx-xx
Xxxxx, 000 Xxxxx
Attention: Xxxxx Xxxxx, M.D.
President and Chief
Executive Officer
- 18 -
